Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

PMGC Holdings (ELAB) Research & Development (2022 - 2025)

PMGC Holdings (ELAB) has disclosed Research & Development for 4 consecutive years, with $40692.0 as the latest value for Q4 2025.

  • Quarterly Research & Development rose 134.83% to $40692.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $204073.0 through Dec 2025, up 245.7% year-over-year, with the annual reading at $160376.0 for FY2025, 461.13% up from the prior year.
  • Research & Development hit $40692.0 in Q4 2025 for PMGC Holdings, down from $64273.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $89.3 million in Q3 2022 to a low of -$167.7 million in Q4 2022.
  • Historically, Research & Development has averaged -$5.6 million across 4 years, with a median of $37758.0 in 2024.
  • Biggest five-year swings in Research & Development: tumbled 99.93% in 2023 and later soared 1468.4% in 2025.
  • Year by year, Research & Development stood at -$167.7 million in 2022, then soared by 99.86% to -$242590.0 in 2023, then soared by 107.14% to $17328.0 in 2024, then surged by 134.83% to $40692.0 in 2025.
  • Business Quant data shows Research & Development for ELAB at $40692.0 in Q4 2025, $64273.0 in Q3 2025, and $66675.0 in Q2 2025.